West Pharmaceutical Services Current Ratio 2010-2024 | WST

Current and historical current ratio for West Pharmaceutical Services (WST) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. West Pharmaceutical Services current ratio for the three months ending September 30, 2024 was 3.00.
West Pharmaceutical Services Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $1.55B $0.52B 3.00
2024-06-30 $1.48B $0.63B 2.34
2024-03-31 $1.69B $0.65B 2.61
2023-12-31 $1.94B $0.67B 2.88
2023-09-30 $1.97B $0.53B 3.70
2023-06-30 $1.87B $0.51B 3.66
2023-03-31 $1.94B $0.54B 3.62
2022-12-31 $1.92B $0.52B 3.70
2022-09-30 $1.73B $0.46B 3.80
2022-06-30 $1.77B $0.57B 3.13
2022-03-31 $1.69B $0.59B 2.89
2021-12-31 $1.74B $0.59B 2.93
2021-09-30 $1.60B $0.56B 2.86
2021-06-30 $1.48B $0.47B 3.13
2021-03-31 $1.33B $0.48B 2.75
2020-12-31 $1.37B $0.50B 2.73
2020-09-30 $1.24B $0.45B 2.77
2020-06-30 $1.11B $0.38B 2.96
2020-03-31 $0.98B $0.34B 2.84
2019-12-31 $1.06B $0.34B 3.10
2019-09-30 $1.00B $0.34B 3.00
2019-06-30 $0.94B $0.31B 3.02
2019-03-31 $0.87B $0.30B 2.88
2018-12-31 $0.89B $0.28B 3.15
2018-09-30 $0.85B $0.29B 2.94
2018-06-30 $0.77B $0.29B 2.67
2018-03-31 $0.74B $0.26B 2.82
2017-12-31 $0.74B $0.28B 2.66
2017-09-30 $0.78B $0.30B 2.59
2017-06-30 $0.72B $0.29B 2.48
2017-03-31 $0.65B $0.26B 2.54
2016-12-31 $0.64B $0.24B 2.66
2016-09-30 $0.66B $0.24B 2.78
2016-06-30 $0.66B $0.24B 2.75
2016-03-31 $0.63B $0.24B 2.62
2015-12-31 $0.67B $0.31B 2.14
2015-09-30 $0.68B $0.30B 2.27
2015-06-30 $0.68B $0.31B 2.17
2015-03-31 $0.63B $0.30B 2.11
2014-12-31 $0.66B $0.25B 2.61
2014-09-30 $0.68B $0.24B 2.80
2014-06-30 $0.69B $0.22B 3.10
2014-03-31 $0.69B $0.23B 3.02
2013-12-31 $0.65B $0.24B 2.75
2013-09-30 $0.64B $0.25B 2.61
2013-06-30 $0.61B $0.22B 2.80
2013-03-31 $0.59B $0.21B 2.83
2012-12-31 $0.56B $0.26B 2.13
2012-09-30 $0.56B $0.28B 2.02
2012-06-30 $0.52B $0.32B 1.62
2012-03-31 $0.50B $0.30B 1.66
2011-12-31 $0.47B $0.24B 1.94
2011-09-30 $0.50B $0.23B 2.20
2011-06-30 $0.51B $0.19B 2.65
2011-03-31 $0.48B $0.18B 2.63
2010-12-31 $0.44B $0.17B 2.57
2010-09-30 $0.44B $0.16B 2.79
2010-06-30 $0.40B $0.16B 2.55
2010-03-31 $0.41B $0.18B 2.20
2009-12-31 $0.40B $0.17B 2.32
2009-09-30 $0.40B $0.16B 2.45
2009-06-30 $0.40B $0.16B 2.45
2009-03-31 $0.36B $0.14B 2.57
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.854B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95